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Abstract
Background: Aging is a condition of chronic inflammation. In healthy Australians ]64 years, the primary aim
was to determine whether four servings/week of mixed fish (FISH) improves serum cytokines (i.e. C-reactive
protein (CRP), IL-1, IL-6, TNF-a) compared to a diet low in fish (B1 serving/week, CONTROL); the
secondary aims were to assess the effect of the diet on blood pressure and serum lipids (TC, HDL-C, TG,
calculated LDL-C).
Methods: An 8-week randomized, parallel study, stratified by CRP (B3 mg/L vs. ]3 mg/L) on entry to
the study. Compliance was measured using 3-day weighed food records in weeks 1 and 7 of the study. A 12-h
fasting blood sample was taken at baseline and 8-weeks for erythrocyte fatty acids as confirmation of
compliance, and measurement of serum cytokines and lipids. Blood pressure was measured at both time points.
Results: Eighty participants completed the study (mean (SD) age: 69.6 (5.8) years). During week 1 of the
study, mean9SEM daily dietary intake of very long chain omega-3 polyunsaturated fatty acids (VLCN n-3
PUFA) in FISH vs. CONTROL was 1,6769129 mg vs. 2795 mg (pB0.001). Mean (SD) gram intake of
study fish and meat was 121 (45) g and 123 (78) g, for those allocated to FISH and CONTROL, respectively.
Mean9SEM percentage VLCN n-3 PUFA in erythrocytes at 8-weeks was higher in those allocated to
FISH vs. CONTROL (10.290.2% vs. 8.290.3%, pB0.001). There was no between-group difference in CRP
(n80), IL-1b (n33) or IL-6 (n21) concentrations, blood pressure, or lipids, at 8-weeks.
Conclusions: Eight weeks consumption of four servings/week fish did not affect serum cytokine concentrations,
blood pressure or lipids compared to a diet low in fish. In healthy older adults with low inflammatory burden,
our results do not support that short-term consumption of mixed fish has a beneficial effect on selected
cardiovascular biomarkers.
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W
ith aging, the inflammatory process is aggra-
vated. This may be a result of conditions such
as cachexia (1), neurodegenerative diseases
(2, 3), or depression (4). It is recognized that chronic,
low-grade inflammation is associated with increased
risk for cardiovascular, and a number of other, chronic
diseases (5, 6). With aging, blood pressure also generally
increases (7) and elevated blood pressure (140/90) is
a risk factor for cardiovascular disease (CVD), specifi-
cally stroke (8). The ability of very long chain omega-3
polyunsaturated fatty acids (VLCN n-3 PUFA) that are
contained in fish to impact markers of CVD continues
to be investigated; however, clinical trials assessing in-
creased intake of fish in older adults, who are at greater
risk of CVD, are inconclusive.
In Australia, consumption of fish is low (911). In
1995, the estimated mean intake of total VLCN n-3
PUFA in those 65 years was 219 mg/day, to which fish
and seafood products contributed 48% (11). In a more
recent survey of older adults in Australia (n854), the
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mean frequency of finfish/seafood consumption was 1.7
times/week (median intake 173 g), however only 28%
(n242) consumed ]500 mg/day VLCN n-3 PUFA
from finfish/seafood alone (12). These intakes are lower
than current Australian recommendations for fish and
VLCN n-3 PUFA consumption (10).
Findings from some observational studies reveal that
dietary intakes of VLCN n-3 PUFA of ]100 mg/day in
Western countries (1315) or ]470 mg/day in the higher
fish eating country of Japan (16), were associated with
lower concentrations of inflammatory cytokines includ-
ing C-reactive protein (CRP), IL-6, and intercellular- and
vascular adhesion molecules. It is unclear whether con-
sumption of fish in its whole form affects inflammatory
cytokines in healthy older adults. Some observational
studies demonstrated that fish consumption of 100150 g/
week was associated with lower cytokine concentrations
(15), particularly CRP (17, 18), and studies investigating
dietary patterns have found that those which included fish
were also associated with lower CRP concentrations (19,
20). Some intervention studies have assessed the impact of
increased fish consumption on cytokine concentrations
and cardiovascular risk markers in younger (2124) and
older populations (2531). However, specifically in the
studies among older adults, the fish intervention was
either in combination with other omega-3 oils or foods
(28, 31), included patients with non-active/previous cancer
(32) or coronary heart disease (CHD) (30), was based on
guidelines to lower cholesterol (27), was only conducted in
men (25, 26) or the included fish was modified by different
feeds (25, 30). The current study is therefore the first to
assess a high fish diet in both healthy older men and
women, without risk factors for CVD, and in conjunction
with their usual diet on cytokine concentrations. Only two
of the previous studies compared the fish intervention to
a diet in which either 150 g/day chicken was used as a
reference meal (25) or a mix of 150 g/day lean pork and
chicken for 5 day/week (26). In Australia, recent surveys
have suggested a decline in red meat consumption, even
in the older age groups, whereas consumption of poultry
has been relatively constant (33). Therefore, we chose to
support the consumption of red meat, appropriate for this
age group, by providing four servings/week of red meat to
the CONTROL group.
Only two studies in older adults have assessed fish
intake on blood pressure in which a positive association
was found between a higher intake of fish (34) and higher
serum levels of VLCN n-3 PUFA (35) with lower blood
pressure. In combination with 8-weeks of energy restric-
tion, consumption of salmon three times/week lowered
diastolic blood pressure in young, overweight, 2040 year
olds (36); and consumption of lean fish ]4 times/week
reduced blood pressure in patients with CHD (37). No
RCTs were found that specifically investigated the effects
of increased fish intake on blood pressure in older adults.
Consumption of a range of mixed fish within the context
of a usual dietary pattern in older adults, who are prone
to some low-grade inflammation and who usually con-
sume a relatively low intake of fish would therefore pro-
vide value in understanding whether increased fish intake
affects cardiovascular risk markers.
The primary aims of the current study were to
determine, in a group of healthy Australian adults ]64
years of age: whether consumption of four servings/week
of mixed types of fish (FISH), improves serum cytokines
(i.e. CRP, IL-1, IL-6, TNF-a) compared to a typical
Australian diet that is lower in fish (B1 serving/week) and
higher in red meat, CONTROL. The secondary aims
were to identify whether consumption of a higher fish diet
improves blood pressure and serum lipids (TC, HDL-
C, TG, and calculated LDL-C) compared to a typical




This study was an 8-week randomized controlled, parallel
study. Participants were randomized to either FISH,
in which participants were provided eight servings of
mixed fish per fortnight, equivalent to 800 mg/day
EPADHA, or CONTROL, in which participants con-
sumed their usual diet as well as eight servings of red meat
per fortnight (equivalent to 17 mg/day EPA and 4 mg/day
DHA, Table 1). The amount of meat provided was 0.5
serving/day (68 g/day) and was based on the recommended
11.5 daily servings of ‘meat, fish, poultry, eggs, nuts and
legumes’ from the Australian Guide to Healthy Eating
for men and women 60 years (38). Participants in both
groups were advised to follow their otherwise usual dietary
and physical activity patterns throughout the 8-week
study. Between study groups, the food provided was
designed to be no greater than 10% different for energy
(kJ), protein (g), saturated fat (g) and sodium (g), except
for total fat, which was nearly double in the FISH diet vs.
CONTROL diet (7.0 g/day vs. 4.7 g/day). Participants
collected their study foods from Flinders Medical Centre
every two weeks, and for those who travelled long
distances, at the 4-week time point. At this time, the study
researcher interviewed each participant to determine
compliance with the study protocol and ease of including
study foods into their regular diet. For participants who
were finding it difficult to consume the study foods, the
study researcher provided verbal motivation for consum-
ing these.
Subjects
A total of 126 community dwelling men and women ]64
years of age expressed interest in the study following
newspaper advertisements, flyers and verbal invitations.
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Ninety-two were eligible for screening; however eight did
not attend. Inclusion criteria were: BMI ]18.5 kg/m2,
usual consumption of 51 serving of fish/seafood per
week, willing to consume eight servings of fish or red
meat per fortnight, able to provide written informed
consent and attend assessment visits at Flinders Medical



















FISH: Weeks 1 and 2
Atlantic salmon-skin off, 145 ga 1,056 32.0 13.6 3.2 59 945 1,035 1,980 
Atlantic salmon-skin off, 145 ga 1,056 32.0 13.6 3.2 59 945 1,035 1,980 
Ocean trout-skin on, 150 ga 1,630 28.2 30.3 7.8 41 1,210 2,200 3,430 
Ocean trout-skin on, 150 ga 1,630 28.2 30.3 7.8 41 1,210 2,200 3,430 
Flavored canned salmon, 95 ga 559 13.3 6.8 1.0 271 114 233 347 
Flavored canned tuna, 95 ga 537 17.3 6.3 0.8 326 17 148 164 
Canned sardines in spring water,
110 ga
710 13.7 12.5 3.4 180 750 1,120 1,880 
Canned pink salmon, 105 g packa 484 18.6 4.9 1.2 280 502 683 1,185 
FISH: Week 3 and 4
Marinated Atlantic salmon-skin off,
145 ga
1,380 27.1 23.5 5.4 312 1,300 1,530 2,830 
Marinated Atlantic salmon-skin off,
145 ga
1,380 27.1 23.5 5.4 312 1,300 1,530 2,830 
Canned red salmon, 105 ga 557 18.4 6.9 1.5 324 494 762 1,256 
Flavored canned salmon, 95 ga 559 13.3 6.8 1.0 271 114 233 347 
Tuna slices in spring water, 105 ga 397 21.7 0.7 0.2 185 29 215 244 
Lightly seasoned frozen fish fillets,
200 ga
1,340 29.2 14.8 2.0 260 200 500 700 
Canned tuna in spring water, 95 ga 227 12.1 0.5 0.3 139 0.2 20.0 147 
MEAT: Weeks 1 and 2
Beef scotch fillet, lean, raw, 125 gb 758.75 29 9.375 2.875 68.75 30 5 35 33.75
Beef scotch fillet, lean, raw, 125 gb 758.75 29 9.375 2.875 68.75 30 5 35 33.75
Frozen veal schnitzel, 140 gc 1,289 18.06 14.56 4.48 882
Lamb rump, lean, raw, 125 gb 677.5 28.125 5.375 1.75 81.25 23.8 13 36.8 46.3
Beef scotch fillet, lean, raw, 125 gb 758.75 29 9.375 2.875 68.75 30 5 35 33.75
Ham deli meat, 50 gc 184 7.9 1.5 0.3 293
Ham deli meat, 50 gc 184 7.9 1.5 0.3 293
MEAT: Week 3 and 4
Beef mince, 10% fat, 150 gb 1,112 30.15 16.2 5.85 96 141 31.5 172.5 217.5
Beef mince, 10% fat, 150 gb 1,112 30.15 16.2 5.85 96 141 31.5 172.5 217.5
Lamb rump, lean, raw, 125 gb 677.5 28.125 5.375 1.75 81.25 23.8 13 36.8 46.3
Beef scotch fillet, lean, raw, 125 gb 758.75 29 9.375 2.875 68.75 30 5 35 33.75
Pork loin chop, 140 gb 440 22.2 1.7 0.6 66 0 6 6 9
Frozen beef satay convenience
meal, 375 gc
2,378 25.9 20.6 8.6 675
Beef scotch fillet, lean, raw, 125 gb 758.75 29 9.375 2.875 68.75 30 5 35 33.75
Pork loin chop, 140 gb 440 22.2 1.7 0.6 66 0 6 6 9
aAnalyses were conducted by AsureQuality Limited (Auckland New Zealand). All samples submitted for analyses were composite samples from a
minimum of three production dates. Samples were homogenized with stainless steel cutters, packed in plastic bags protected from light and frozen
before being shipped to the laboratory. All samples were analyzed in duplicates. Reagent blank (same procedure but omitting the sample), spikes and
standard reference materials were prepared as per the laboratory’s standard operating procedure. The laboratory contracted to undertake the analyses
was accredited and complied to the requirements for the competence of testing and calibration laboratories ISO/IEC 17025:2005.
bNutrient profiles were obtained from AUSNUT 2007 or c nutrient information panel of actual products.
Cardiovascular biomarkers following a high fish intake in healthy older Australians
Citation: Food & Nutrition Research 2014, 58: 20369 - http://dx.doi.org/10.3402/fnr.v58.20369 3
(page number not for citation purpose)
Centre. Exclusion criteria were: allergies to fish/seafood,
vegetarian, intake of lipid-lowering medications; intake
of lipid-lowering supplements (e.g. psyllium, fish oil
capsules, soy lecithin, phytoestrogens or to cease 3 weeks
prior to study commencement), use of anti-inflammatory
medications on a regular basis or if experiencing an acute
episode within 1 week of the screening visit, presence of
diabetes, liver, kidney, thyroid diseases (unless controlled
and stable on replacement medication), presence of other
endocrine disorders from self-reported medical history,
weight loss or gain of 10% body weight in the prior
6 months, or clinically diagnosed depression or dementia.
Of the 84 respondents who attended the clinic visit,
all were eligible for the RCT, however one participant
withdrew before randomization, leaving 83 to be rando-
mized. The Southern Adelaide Clinical Research Ethics
Committee granted ethical approval. The clinical trial
was registered with the Australian New Zealand Clinical
Trials Registry, trial number 336393. Written informed
consent was obtained from all subjects.
Clinic measurements
All assessments were taken at baseline and at 8-weeks.
Body weight and height were measured to 0.1 kg and
0.1 cm, respectively, while wearing light clothing and
without shoes, on a digital height and weight wireless
measuring station (SECA, model 284, Germany). Blood
pressure was measured using a hospital grade non-invasive
automated sphygmomanometer (Criticare Systems Inc.,
USA). After 5 min of rest, blood pressure was taken three
times and the average reading was used.
Laboratory measurements
At baseline and at 8-weeks, participants arrived at the
clinic following a 12-h overnight fast in which only water
was allowed to be consumed. Nursing staff confirmed the
fast before taking 10 ml of blood by asking them their
last mealtime from the prior evening. After 30 min of
clotting, whole blood was centrifuged at 3,500 RPM,
248C for 10 min (Beckman GS-6R). Serum was separated,
aliquoted, and stored at 808C until all participants
completed the study. Aliquots were then thawed, and total
cholesterol, HDL-C, triacylglycerol, and high-sensitive
CRP (hs-CRP) (limit of detection 50.3 mg/L) were
analyzed enzymatically (Siemens Advia 2,400 Chemistry
System). LDL cholesterol was calculated using the
Friedewald Equation (39). Inflammatory cytokines (IL-
6, IL-1b and TNF-a) were measured using commercial
cytokine enzyme-linked immunosorbent assays (ELISA)
(BD Systems, San Diego, CA). The limits of detection for
IL-6, IL-1b and TNF-awere allB5 pg/ml. The inter-assay
and intra-assay CV for IL-6 were 68 and 23%, for IL-1b
were 710 and 24% and for TNF-a were 35 and 13%,
respectively.
Compliance
Three-day weighed food records
Dietary intakes were measured using 3-day weighed food
records (any 2 week days and any 1 weekend day) and
were completed during week 1 and week 7 of the study to
assess study compliance. All participants were instructed
on how to fill out their food records at the baseline visit
and were provided a set of digital food scales (Kenwood
DS607 Digital Food Scales, Australia).
Fatty acids
Compliance was assessed using measurement of fatty
acids in erythrocytes and plasma phospholipids (DHA,
DPA, EPA, total n-3 fatty acids, total n-6 fatty acids, and
total saturated fatty acids) collected into heparinized
tubes.
Lipid extraction from plasma phospholipids. Plasma was
separated from erythrocytes by centrifugation (5 min at
1,000 g) and 1 ml plasma was added to 0.5 ml saline, 2 ml
of methanol and 4 ml of chloroform. The samples were
centrifuged and the lower chloroform phase (containing
lipids) was transferred to a 20 ml scintillation vial and
evaporated to dryness by a vacuum concentrator. 150 ml
of chloroform: methanol (9:1) was added to the vial in
preparation for thin layer chromatography (TLC).
Lipid extraction from erythrocytes. Erythrocytes were
rinsed free of plasma three times in isotonic saline and
1 ml packed cells were mixed with 0.5 ml saline, 2 ml of
isopropanol, and 4 ml of chloroform. The samples were
centrifuged and the lower chloroform phase was trans-
ferred to a vial and evaporated to dryness. About 150 ml
of chloroform: methanol (9:1) was added to the vial in
preparation for TLC.
Thin Layer Chromatography. The phospholipids from
all tissues were isolated using TLC (Silica gel 60 H,
Merck, Darmstadt Germany) using a ratio of 3:1 (v/v)
of petroleum spirits: acetone. Phospholipid bands were
visualized under an ultraviolet lamp and scraped into vials
containing 1% H2SO4 in methanol for trans-esterification
for 3 h at 708C. After cooling, water and n-heptane were
added to the mixture and the upper layer containing the
resulting fatty acid methyl esters (FAME) was transferred
into 2 ml gas liquid chromatography (GLC) vials contain-
ing anhydrous Na2SO4.
Gas chromatographic analysis of FAME. FAMEs were
separated and quantified using a Hewlett-Packard 6,890
gas chromatograph equipped with a 50 m capillary column
(0.33 mm ID) coated with BPX-70 (0.25 m film thickness
SGE Pty Ltd Victoria Australia). The injector temperature
was set at 2508C and the detector (flame ionization)
temperature at 3008C. The initial oven temperature was
Jessica A. Grieger et al.
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1408C and was programmed to rise to 2208C at 58C
per minute. Helium was used as the carrier gas at a
velocity of 35 cm per second. Individual fatty acids were
identified by comparison with known fatty acid methyl
ester standards (Nuchek Prep Inc., Elysian, USA) and
expressed as a percentage of total fatty acids (weight
percentage) (40).
Sample size
The sample size was based on previous studies that
showed a 19% (0.4 mg/L) reduction in CRP following
360 mg/day EPADHA as fish oil for 3 weeks in
hyperlipidemic patients (n15, 55 years) (41); a 13%
(0.19 mg/L) reduction in CRP following 2  150 g/week
of salmon for 6 months (1,400 mg/day total omega-3;
n54, 54 years) (29); and an 8% (0.13 mg/L) reduction
in CRP following 2150 g/week cod (257 mg/day total
omega-3 for 6 months; n51, 57 years) (29). The
calculated sample sizes required from these respective
studies were 20, 8 and 17. As the target study population
was older, free of disease, and may have a slightly higher
inflammatory status at baseline, we anticipated a larger
sample size would be required to find a similar signifi-
cant change in CRP from the FISH diet. Therefore,
the current study aimed to recruit 90 subjects in order
to have 40 subjects complete the 8-week study in each
group, with sufficient power to detect a CRP change of
13% (0.24 mg/L) for those allocated to the FISH diet.
An independent statistician using ralloc.ado version 3.6.1
in Stata version 11.1 created the randomization schedule.
The randomization was stratified by screening CRP
concentrations (B3 mg/L vs. ]3 mg/L) in order to deter-
mine whether diet affected CRP differently between those
with different baseline CRP concentrations. Block sizes
of 2, 4 and 6 were used and were chosen at random;
treatment allocations were randomly permuted and bal-
anced within blocks.
Statistical analyses
Statistical analyses were performed using SPSS 19 for
Windows (SPSS, Inc., Chicago, IL, USA). Frequencies
and descriptives of the study population are reported as
mean (SD), or between groups as mean (SEM). Prior to
hypothesis testing, data were examined for normality.
Distribution was normal except for CRP, IL-1 and IL-6,
which were normalized using natural logarithmic trans-
formation with the exponentiated (geometric) means (95%
confidence intervals) presented. Primary and secondary
outcomes at 8-weeks were tested using ANCOVA (uni-
variate analysis of variance, adjusting for baseline values).
As a secondary analysis, the absolute change in CRP was
assessed with CRP strata as a fixed factor (groupCRP
stratification interaction), without adjustment for baseline
CRP. Adjustment for multiple comparisons was made




A total of 83 participants started the study; however
one participant withdrew from the FISH diet (too ill to
Table 2. Baseline and 8-week measurements amongst the study population
Baseline Week 8
Controla Fisha Controla Fisha
n n n n
Weight (kg) 37 73.892.1 43 75.792.2 37 73.692.0 43 75.892.1
BMI (kg/m2) 37 26.490.6 43 26.590.6 37 26.390.6 43 26.590.6
Systolic blood pressure (mmHg) 37 12692 43 12692 37 12693 43 12493
Diastolic blood pressure (mmHg) 37 6791 43 6991 37 6691 43 6892
CRP (mg/L)b 37 0.8 (0.5, 1.3) 43 1.17 (0.8, 1.8) 37 0.8 (0.5, 1.3) 43 1.0 (0.7, 1.5)
IL-1b (pg/ml)b,c 15 6.9 (4.7, 10.1) 18 8.11 (5.3, 12.4) 15 7.7 (6.2, 9.4) 18 7.3 (6.0, 8.8)
IL-6 (pg/ml)b,c 10 7.9 (5.4, 11.4) 11 7.21 (5.4, 9.7) 10 7.5 (5.9, 9.6) 11 7.7 (5.2, 11.4)
Total cholesterol (mmol/L) 37 5.590.2 43 5.590.1 37 5.490.2 43 5.690.1
HDL-C (mmol/L) 37 1.690.1 43 1.790.1 37 1.790.1 43 1.890.1
LDL-C (mmol/L) 37 3.390.1 43 3.290.1 37 3.290.1 43 3.490.1
Triacylglycerol (mmol/L) 37 1.490.1 43 1.190.1 37 1.390.1 43 1.090.1
BMI: body mass index; CRP: C-reactive protein; IL-1b: interlukin-1 beta; IL-6: interleukin 6; HDL-C: high-density lipoprotein cholesterol; LDL-C:
low-density lipoprotein cholesterol.
aData reported as mean9standard error of the mean.
bData reported as geometric means (95% CI).
cValues only reported if above limit of detection.
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continue, aged 81 years) and two withdrew from the
CONTROL diet (n1 did not turn up for final visit
despite several phone calls and emails, aged 72 years; and
n1 chose to continue with Zocor medication 2 weeks
into the study, aged 66 years), leaving 80 participants to
complete the study. The mean (SD) age of completed
participants was 69.6 (5.8) years (range 6485 years) and
51% were female. Mean (95% CI) baseline CRP concen-
trations of the completed participants in the low and
high CRP strata are shown in Supplementary file. There
were no baseline differences in CRP strata concentrations
between those allocated to the FISH diet and those
allocated to the CONTROL diet. Characteristics of the
study participants are represented in Table 2.
Study compliance
Food intake
Table 3 describes the mean gram intake and some nutrient
intakes consumed from the study fish and meat, as well as
by non-study fish/meat during week 1 and week 7 of the
study, in FISH and CONTROL. For those allocated to
the FISH diet, no other fish was consumed at either time
point. For those allocated to the CONTROL diet, one
serving of fish was consumed by one participant in week 1
and week 7 of the study. Supplementary file shows the
mean energy and nutrient intakes between groups during
week 1 and week 7 of the study. Intakes of VLCN n-3
PUFA was higher for those allocated to the FISH diet
at both time points compared to those allocated to the
CONTROL diet, whereas the intakes of most other
nutrients were generally not different between groups.
Fatty acids
Mean9SEM percentage VLCN n-3 PUFA in erythro-
cytes at 8-weeks was higher for those allocated the
FISH diet vs. CONTROL diet (10.290.2% vs. 8.290.3%,
pB0.001) (Table 4) and this was also true of plasma
phospholipids (Supplementary file). Percentage total n-6
fatty acids in plasma phospholipids, but not erythrocytes,
was lower in those allocated the FISH diet vs. CONTROL
diet at 8-weeks.
Primary outcomes: inflammatory cytokines
The mean values of CRP between groups are reported
in Table 2. There was no difference in 8-week CRP con-
centrations between groups. In the secondary analysis
assessing the change in CRP over time, there was a diet
effect according to CRP strata (p0.017): in CONTROL,
those with high CRP had a larger increase in CRP
over the study (n7, D3.37 (3.24) mg/L) compared
to those with low CRP (n30, D0.14 (0.23) mg/L,
p0.046, Fig. 1). The change in CRP in the FISH
group was not different between those with low (n32,
D0.13 (0.18) mg/L) or high CRP (n11, D1.15
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All of the TNF-a serum samples were below the limits
of detection (B5 pg/ml) and were therefore unable to be
included in the analyses. Mean concentrations of IL-1b
and IL-6 that were detectable in serum are reported in
Table 2. Diet allocation had no effect on IL-1b or IL-6 at
8-weeks.
Secondary outcomes: lipids, blood pressure
There was no effect of diet allocation on blood pressure
or lipids (Table 2).
Discussion
This project was the first to be conducted among a group
of healthy older adults in Australia, to assess whether
8-weeks consumption of four servings/week mixed fish
reduces inflammatory cytokines, compared to a typical
Australian diet that is lower in fish and higher in red
meat. The current study identified that compared to a low
fish diet, consumption of four servings/week fish did not
affect concentrations of cytokines overall, nor have any
effect on the secondary outcomes, blood pressure and
lipids. In a secondary analysis assessing the change in
CRP over time, there was a diet effect according to CRP
strata; those with CRP concentrations ]3 mg/L in the
control group had larger increases in CRP over the study
compared to those with CRP concentrations B3 mg/L;
fish had no effect on the change in CRP in participants
with CRP ]3 or B3 mg/L.
Compliance with the intervention was appropriate as
we found an increase in VLCN n-3 PUFA in erythrocytes
in the fish group, and a decrease in the control group.
Consumption of fish and meat, assessed by the 3-day
weighed food records in weeks 1 and 7, was also
satisfactory with high intakes of VLCN n-3 PUFA in
the fish group. The amount of non-study meat that was
consumed at both time points was similar between
groups, and it was evident that the control group adhered
to the study protocol as, except for one participant, no
fish was consumed. We did not find any changes in
percent n-6 fatty acids or DPA in erythrocytes (or plasma
phospholipids) in the control group, therefore we can
speculate that intake of red meat during the study period
was comparable to usual intake.
In the current study, the increased consumption of fish
did not decrease serum cytokines. The mechanisms
relating long chain fatty acids and inflammation are
emerging and are the result of the increased incorpora-
tion of VLCN n-3 PUFA into plasma phospholipids (42).
Arachidonic acid (ARA, an omega 6 PUFA) is usually
the major substrate for eicosanoid synthesis; eicosanoids
are the most important mediators and regulators of
inflammation (43). The incorporation of the VLCN n-3
PUFA (EPA and DHA) occurs at the expense of ARA.
Thus, the normal pro-inflammatory response that would
occur in response to ARA and its derivatives (e.g.
prostaglandins, thromboxanes and leukotrienes) is re-
duced. The increased incorporation of VLCN n-3 PUFA
and decreased ARA leads to a dampening of the pro-
inflammatory state, and toward an anti-inflammatory
state. Therefore, the fact that the increased intake of fish
did not impact measures of inflammation indicates that
either the dose of VLCN n-3 PUFA may have been too
low, or that initial inflammatory status was not high
enough to identify a notable effect. However, the sample
size in which concentrations of IL-1b (n33) and IL-6
(n21) was detected was small and therefore the low
statistical power along with large variation in cytokine
concentrations, would partly explain our result. Cell
culture studies and some animal feeding studies have
shown that cytokine inhibition by omega-3 is mediated
by inactivation of NFkB, a principle transcription factor
(44). It would have been of interest to assess gene
expression in this study and assess how fatty acids might
affect activation of NFkB in our healthy older adult
sample.
Table 4. Mean (9SEM) percentage concentrations of fatty acids
measured in erythrocytes at baseline and after 8-weeks consumption
of a CONTROL (n37) or FISH (n43) diet
Group Baseline (%) Week 8 (%)
Total saturated fatty Control 44.290.2 44.190.3
acids Fish 44.190.2 44.890.2
Total n-6 fatty acids Control 27.090.4 26.690.4
Fish 27.290.4 25.590.3$
Arachidonic acid Control 12.090.3 12.490.2
Fish 12.590.2 11.890.2*
Total monounsaturated Control 18.490.2 17.890.2
fatty acids Fish 18.290.2 17.790.2
Total n-3 fatty acids Control 9.790.4 8.490.3
Fish 9.390.3 10.490.2%
Alpha linoleic acid Control 0.14790.008 0.14990.007
Fish 0.12690.008 0.13690.008
Linoleic acid Control 10.390.2 9.890.2
Fish 10.290.2 9.890.2
VLCN n-3 PUFA Control 9.590.4 8.290.3
Fish 9.290.3 10.290.2%
EPA Control 1.590.1 1.190.3
Fish 1.390.1 1.790.1%
DPA Control 3.090.1 2.890.1
Fish 2.890.1 2.890.1
DHA Control 5.090.2 4.490.2
Fish 5.090.2 5.790.1%
SEM: standard error of the mean; VLCN n-3 PUFA: very long chain
omega-3 polyunsaturated fatty acids; EPA: eicosapentaenoic acid; DPA:
docosapentaenoic acid; DHA: docosahexanoic acid.
*pB0.05, $pB0.01, %pB0.001 between groups (analyzed using uni-
variate analysis of variance, adjusting for baseline values).
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Several other RCTs in older adults have assessed
fish consumption on inflammatory cytokines (2531);
however, these studies were conducted in those who
were medically unwell or were in conjunction with other
therapies. The increase in VLCN n-3 PUFA following the
fish diet in our study was slightly lower compared to other
intervention studies utilizing fish; however, the prescribed
daily VLCN n-3 PUFA dose from fish in our study was
also generally lower (800 mg/day vs. 1.2 g/day).
Although our intention was to use healthy individuals,
the specific use of older adults was novel and we
anticipated a higher inflammatory status as a result of
the aging process (irrespective of this group having no risk
factors for CVD). Mean CRP values at baseline were
comparable to those previous studies that assessed fish
and inflammation, but the effect of increasing VLCN n-3
PUFA appears most effective with higher levels of
inflammation. This conclusion was also indicated in a
previous review, such that patients with an inflammatory
condition might be more sensitive to the immunomodu-
latory effects of VLCN n-3 PUFA compared to healthy
subjects (45).
We used CRP as the primary outcome measure as it has
been consistently found to be an independent predictor
of CVD (46). The use of an hs-CRP assay also enables
low levels of CRP to be detected in peripheral blood,
indicating low-grade inflammation (47). We acknowledge
that because CRP is an acute-phase reactant some intra-
individual variability may occur in testing, and low-grade
inflammation can produce minor elevations of CRP.
Although we attempted to have all participants’ blood
taken while they were free of any symptomatic illness, the
low level of CRP at baseline suggests that amongst healthy
older adults, the benefits of increased consumption does
not provide an anti-inflammatory benefit. It would be of
interest to assess the effects of increased fish consumption
in a larger group of healthy adults with CRP 3 mg/L,
and to determine whether a clinically relevant reduction in
CRP occurs.
The effect of VLCN n-3 PUFA on blood pressure has
been described; however, the positive effect of high dose
VLCN n-3 PUFA supplementation on blood pressure is
small (48). For example, in a meta-regression of 36 RCTs,
VLCN n-3 PUFA supplementation decreased systolic and
diastolic blood pressure in those 45 years by 2.72 and
2.32 mmHg, respectively; greater than what was ob-
served for those 545 years (48). However, the median
intake of VLCN n-3 PUFA (3.7 g/day) was far higher than
that provided by fish in the current study, and would not be
a usual intake of VLCN n-3 PUFA when supplements are
not consumed. The effect of increased consumption of fish
on blood pressure in older adults has not been specifically
evaluated. Therefore, this outcome provided another novel
component to our study. In our healthy group of older
adults, we did not find an effect of increased fish intake
on blood pressure. The beneficial effect of fish on blood
pressure is thought to be through the increased synthesis
of nitric oxide, a potent vasodilator, as well as the reduced
production of the vasoconstrictor thromboxane A2, thus
decreasing platelet aggregation and improving arterial
compliance (49). As the meta-regression by Geleijnse et al.
indicated that a greater effect on blood pressure was
observed in hypertensives rather than normotensives (48),
it is possible that we might have observed an effect on
blood pressure if our study population also had elevated
blood pressure. Nevertheless, further dose-response inter-
vention studies assessing the relative effects of higher
VLCN n-3 PUFA intakes on blood pressure in older
adults are required, as well as the effect of increased fish
intake in older adults with hypertension would be of value.
In our secondary analysis, among the small sample
of adults with high baseline CRP concentrations, an
Fig. 1. Mean adjusted changes in CRP over 8-weeks between CONTROL and FISH.
GroupCRP strata interaction (p0.017) using the Sidak test for multiple comparisons.
*p0.046 between high and low CRP in CONTROL.
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increase in CRP was evident following the control diet,
compared to those with low CRP on the control diet.
This was a surprising result and it appears this type of
diet could be unfavorable in this small group of healthy
older adults, at least in the short-term. One study in adult
women previously indicated that a higher intake of meat
was associated with a higher level of CRP (50); whereas
another study reported a diet high in red meat did not
increase markers of oxidative stress and inflammation in
men and women (51). These findings lend for further
studies to assess the potential effects of CRP following a
low fish, higher red meat diet, in healthy older adults with
high CRP.
For Australian adults to lower their risk for CHD, it is
recommended that 500 mg/day of VLCN n-3 PUFA is
consumed (two or three servings (150 g serve) of oily fish
per week), and for patients with documented CHD is 1,000
mg/day (10). Therefore, the intention to supply the fish in
this study at an amount nearly twice the current recom-
mendations was to assist in compliance for a relatively
short time-frame, as consumption of fish in this amount is
not usual (52, 53). Our results demonstrated that short-
term consumption of a high fish diet is feasible. However, a
higher fish intake in older adults who do not display
cardiovascular and metabolic co-morbidities are unlikely
to benefit from a diet higher in fish in an effort to further
reduce CVD biomarkers, and thus, does not provide
evidence that our results can be generalized into a public
health recommendation for fish. We acknowledge that
consumption of this amount of fish in the longer term
is unlikely to be sustainable and other sources such as a
fish oil supplement may be appropriate, if indeed, future
studies identified a benefit from further reduction of
already desirable cardiovascular biomarkers amongst
older adults.
The study duration of 8-weeks was chosen as this time-
frame is sufficient to alter the membrane composition and
incorporation of omega-3 fatty acids in cells and tissues
(54); and changes in IL-6 and TNF-a, which are mediators
of CRP, can be noted within 6-weeks following VLCN n-3
PUFA in doses slightly higher (27) and much higher (55,
56) than that used in the current study. Provision of red
meat in the control diet was based on the recommended
11.5 daily servings of ‘meat, fish, poultry, eggs, nuts and
legumes’ from the Australian Guide to Healthy Eating
for men and women 60 years (57) and that intake of
red meat is generally lower than intake of poultry. We
provided four servings of red meat per week, equivalent to
0.5 serving/day red meat, or 68 g/day. This intake of
meat was intermediate compared to consumption data in
previous Australian studies (52, 53). In our study, we did
not assess food intake prior to study commencement,
therefore it is unclear whether the meat we provided is a
usual intake for this group. We speculated that randomi-
zation would account for any baseline differences and
the primary purpose of the dietary assessment was for
compliance purposes. Another measure of dietary intake
at baseline would have increased the burden for partici-
pants. We found good overall compliance with the study
foods; however we did not specify which 3 days food
was to be weighed nor on which days the study foods were
to be consumed. This presents a further limitation to the
study. Finally, we did not use high-sensitive ELISAs for
IL-1, IL-6 and TNF-a, resulting in few samples with
detectable concentrations. High-sensitive ELISAs would
have enabled us to identify detectable cytokine concentra-
tions, and therefore would have assisted in determining
whether a higher fish diet affects a composite of cytokine
concentrations.
Conclusions
Eight weeks consumption of four servings of fish per week
did not affect serum cytokine concentrations, lipids or
blood pressure compared to a diet low in fish. In healthy
older adults with low inflammatory burden, our results do
not support that short-term consumption of mixed fish
has a beneficial effect on selected cardiovascular biomar-
kers. Although a small sample size, the secondary analysis
indicates that a diet more consistent with Australian
dietary guidelines that is higher in meat and lower in
fish, might increase CRP among older adults with CRP
]3 mg/L. Further, larger studies utilizing the same high
fish intervention are required to substantiate this finding
in healthy older adults with high CRP.
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